| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/13/2008 | EP1885389A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 02/13/2008 | EP1885379A2 Compounds and methods for treating seizure and paroxysmal disorders |
| 02/13/2008 | EP1885377A2 Structured phospholipids for treating autoimmune and neurodegenerative diseases |
| 02/13/2008 | EP1885369A2 Fused heterocyclic compounds, and compositions and uses thereof |
| 02/13/2008 | EP1885367A2 Method for the treatment of noise phobia in companion animals |
| 02/13/2008 | EP1885363A1 Use of 3,11b-cis-dihydrotetrabenazine for the treatment of symptons of huntington' s disease |
| 02/13/2008 | EP1885360A2 Inhibition of neuronal damage |
| 02/13/2008 | EP1885351A1 Methods and compositions for the treatment of pain |
| 02/13/2008 | EP1885350A2 Formulations and methods for treating amyloidosis |
| 02/13/2008 | EP1885348A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 02/13/2008 | EP1885333A1 Pharmaceutical formulation of apomorphine for buccal administration |
| 02/13/2008 | EP1885332A2 Use of an artificial sweetener to enhance absorption of nicotine |
| 02/13/2008 | EP1750735B1 Use of an extract of aloysia/verbrena/lippia triphylla/citridora for the preparation of a medicament for the treatment of chronic and/or inflammatory diseases |
| 02/13/2008 | EP1680421B1 Use of tricyclic compounds as glycine transport inhibitors |
| 02/13/2008 | EP1648896B1 7-substituted 3-nitro-pyrazolo [1,5-a] pyrimidines |
| 02/13/2008 | EP1578915A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 02/13/2008 | EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1513796B1 Phenyloxyalkanoic acid derivatives as hppar activators |
| 02/13/2008 | EP1480973B1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| 02/13/2008 | EP1463716B1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | EP1379283B1 Identification of target-specific folding sites in peptides and proteins |
| 02/13/2008 | EP1335747B1 A composition of sodium channel blocking compound |
| 02/13/2008 | EP1313703B1 Prodrugs to nmda receptor ligands |
| 02/13/2008 | EP1303272B1 Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease |
| 02/13/2008 | EP1289507B1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
| 02/13/2008 | EP1207200B1 High affinity choline transporter |
| 02/13/2008 | EP1147106B1 Process for the preparation of alkyl mercapto methyl ergoline derivatives |
| 02/13/2008 | EP1044189B1 Aryl fused azapolycyclic compounds |
| 02/13/2008 | EP0833652B1 Novel kappa receptor selective opioid peptides |
| 02/13/2008 | EP0755454B1 Aav-mediated delivery of dna to cells of the nervous system |
| 02/13/2008 | CN101124247A Antibodies directed against amyloid-beta peptide and methods using same |
| 02/13/2008 | CN101124232A 烟碱乙酰胆碱受体的配体 Nicotinic acetylcholine receptor ligands |
| 02/13/2008 | CN101124226A 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 02/13/2008 | CN101124224A Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 02/13/2008 | CN101124222A Tetrahydroquinoline analogues as muscarinic agonists |
| 02/13/2008 | CN101124217A CGRP receptor antagonists |
| 02/13/2008 | CN101124216A Heterocyclic MCHr1 antagonists and their use in therapy |
| 02/13/2008 | CN101124210A Tetralin and indane derivatives and uses thereof |
| 02/13/2008 | CN101124206A 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
| 02/13/2008 | CN101124205A Substituted aminopyridines and uses thereof |
| 02/13/2008 | CN101124200A Methods and fluorinated compositions for treating amyloid-related diseases |
| 02/13/2008 | CN101123993A Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/13/2008 | CN101121751A PTD-tyrosine hydroxylase catalysis region fusion protein and application thereof |
| 02/13/2008 | CN101121745A Small molecular acidity peptide, extraction method thereof and pharmaceutical composition using the same as active ingredient |
| 02/13/2008 | CN101121702A Phenoxy indanone derivatives containing alkylamino side-chain, preparation method and use thereof |
| 02/13/2008 | CN101121696A Metal salt of pyritinol and hydrate of the same |
| 02/13/2008 | CN101121677A Agmatine sulfate dihydrate and medical use thereof |
| 02/13/2008 | CN101121016A Traditional Chinese medicine composition for treating neurasthenia and its preparation method |
| 02/13/2008 | CN101120973A Internal-applied traditional Chinese medicine for treating insomnia with the stagnation of liver-qi and changes into liver-fire |
| 02/13/2008 | CN101120946A Medicine for treating alzheimer's disease |
| 02/13/2008 | CN101120940A Application of tanshinone IIA sodium sulfonate as blood-brain barrier protecting agent in cerebral diseases |
| 02/13/2008 | CN101120934A Compositions for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with menthylphenidate |
| 02/13/2008 | CN101120929A Gabapentin stomach retention sustained-release composition |
| 02/13/2008 | CN101120813A Carbonic acid beverage for treating insomnia and preparation method thereof |
| 02/13/2008 | CN101120812A Sedative and tranquilizing health-care beverage for treating insomnia and preparation method thereof |
| 02/13/2008 | CN101120811A Sedative and tranquilizing health-care beverage and preparation method thereof |
| 02/13/2008 | CN101120808A Sedative and tranquilizing fruit juice beverage and preparation method thereof |
| 02/13/2008 | CN101120807A Fruit juice beverage for treating insomnia and preparation method thereof |
| 02/13/2008 | CN101120806A Sedative and tranquilizing fruit juice beverage for treating insomnia and preparation method thereof |
| 02/13/2008 | CN101120784A Brain tonic food and preparation method thereof |
| 02/13/2008 | CN101120782A Health-care beverage for treating insomnia and preparation method thereof |
| 02/13/2008 | CN101120781A Fruit juice beverage useful for sleeping and preparation method thereof |
| 02/13/2008 | CN101120780A Health-care beverage useful for sleeping and preparation method thereof |
| 02/13/2008 | CN101120779A Carbonic acid beverage useful for sleeping and preparation method thereof |
| 02/13/2008 | CN101120774A Medical food for treating insomnia |
| 02/13/2008 | CN100368414C Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368409C Novel 8-aza-bicyclo not 3.2.1|octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/13/2008 | CN100368404C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/13/2008 | CN100368398C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 02/13/2008 | CN100368397C Prodrugs to d-prolines |
| 02/13/2008 | CN100368015C Medicine for relieving drunk |
| 02/13/2008 | CN100368007C Medication for anti senile dementia as well as preparation method usage |
| 02/13/2008 | CN100367976C Hypericum perforatum extract and its preparation process |
| 02/13/2008 | CN100367971C Baicalin dropping pill and its preparing method |
| 02/13/2008 | CN100367970C Use of kaempferol and its derivative in preparing medicines for depression or dementia |
| 02/13/2008 | CN100367966C Tetrodotoxin oil phase formulation preparation method |
| 02/13/2008 | CN100367965C Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 02/13/2008 | CN100367951C Butyl benzene phthalein vein emulsion and its application |
| 02/13/2008 | CN100367946C Gabapentin analogues for fibromy algia and other disorders |
| 02/13/2008 | CN100367945C Pharmaceutical microspheres of valproic acid for oral administration |
| 02/13/2008 | CN100367943C Propofol-containing fat emulsions |
| 02/13/2008 | CN100367930C Spontaneously dispersible N-benzoyl staurosporine compositions |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329777 Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis |
| 02/12/2008 | US7329754 modulators of the monoamine receptors, in particular the serotonin, dopamine and norepinephrine receptors, and the biogenic amine transporters for serotonin, dopamine and norepinephrine; |
| 02/12/2008 | US7329753 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 02/12/2008 | US7329749 Piperazinylcarbonylquinolines and -isoquinolines |
| 02/12/2008 | US7329746 Ring structures C6.C6.C13N and C6.C6.C12NO |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329677 2-[3-(4-Methoxypyridin-2-yl)prop-2-yl]-3H-imidazo[4,5-b]pyridine hydrochloride; transcriptional activation of the iNOS-promoter, tissue and organ damage, cytotoxicity reduction |
| 02/12/2008 | US7329675 Substituted azabicyclic compounds |
| 02/12/2008 | US7329667 A hexahydro-1,5,6,8-tetraaza-acenaphthylene or -1,3,4-triazaphenalene derivatives; treatment of depression and anxiety; inflammatory bowel disease; treatment of conditions mediated by corticotropin-releasing factor |
| 02/12/2008 | US7329662 Pyrazolo-pyridine |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329659 Substituted-1-phthalazinamines as vr-1 antagonists |